N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]benzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]butanamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]cyclopentanecarboxamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]-4-methoxybenzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]pentanamide;propyl N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]carbamate

C136H194N24O8 — CID 159511219

IUPACN-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]benzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]butanamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]cyclopentanecarboxamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]-4-methoxybenzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]pentanamide;propyl N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]carbamate
SMILESCCCC(=O)Nc1cc2[nH]c(C3CCCCC3)nc2cc1N(CC)CC.CCCCC(=O)Nc1cc2[nH]c(C3CCCCC3)nc2cc1N(CC)CC.CCCOC(=O)Nc1cc2[nH]c(C3CCCCC3)nc2cc1N(CC)CC.CCN(CC)c1cc2nc(C3CCCCC3)[nH]c2cc1NC(=O)C1CCCC1.CCN(CC)c1cc2nc(C3CCCCC3)[nH]c2cc1NC(=O)c1ccc(OC)cc1.CCN(CC)c1cc2nc(C3CCCCC3)[nH]c2cc1NC(=O)c1ccccc1
InChIInChI=1S/C25H32N4O2.C24H30N4O.C23H34N4O.C22H34N4O.C21H32N4O2.C21H32N4O/c1-4-29(5-2)23-16-21-20(26-24(27-21)17-9-7-6-8-10-17)15-22(23)28-25(30)18-11-13-19(31-3)14-12-18;1-3-28(4-2)22-16-20-19(25-23(26-20)17-11-7-5-8-12-17)15-21(22)27-24(29)18-13-9-6-10-14-18;1-3-27(4-2)21-15-19-18(24-22(25-19)16-10-6-5-7-11-16)14-20(21)26-23(28)17-12-8-9-13-17;1-4-7-13-21(27)23-19-14-17-18(15-20(19)26(5-2)6-3)25-22(24-17)16-11-9-8-10-12-16;1-4-12-27-21(26)24-18-13-16-17(14-19(18)25(5-2)6-3)23-20(22-16)15-10-8-7-9-11-15;1-4-10-20(26)22-18-13-16-17(14-19(18)25(5-2)6-3)24-21(23-16)15-11-8-7-9-12-15/h11-17H,4-10H2,1-3H3,(H,26,27)(H,28,30);6,9-10,13-17H,3-5,7-8,11-12H2,1-2H3,(H,25,26)(H,27,29);14-17H,3-13H2,1-2H3,(H,24,25)(H,26,28);14-16H,4-13H2,1-3H3,(H,23,27)(H,24,25);13-15H,4-12H2,1-3H3,(H,22,23)(H,24,26);13-15H,4-12H2,1-3H3,(H,22,26)(H,23,24)
InChIKeyMAPYZOSVNPTYLQ-UHFFFAOYSA-N
MW2293.21 g/mol
LogP33.21
Rot. Bonds41

About N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]benzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]butanamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]cyclopentanecarboxamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]-4-methoxybenzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]pentanamide;propyl N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]carbamate

N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]benzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]butanamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]cyclopentanecarboxamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]-4-methoxybenzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]pentanamide;propyl N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]carbamate (PubChem CID 159511219) has the molecular formula C136H194N24O8 and a molecular weight of 2293.21 g/mol. Its IUPAC name is N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]benzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]butanamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]cyclopentanecarboxamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]-4-methoxybenzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]pentanamide;propyl N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]carbamate.

Molecular Properties

Compound NameN-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]benzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]butanamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]cyclopentanecarboxamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]-4-methoxybenzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]pentanamide;propyl N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]carbamate
PubChem CID159511219
Molecular FormulaC136H194N24O8
Molecular Weight2293.21 g/mol
Exact Mass2291.55
IUPAC NameN-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]benzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]butanamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]cyclopentanecarboxamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]-4-methoxybenzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]pentanamide;propyl N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]carbamate
SMILESCCCC(=O)Nc1cc2[nH]c(C3CCCCC3)nc2cc1N(CC)CC.CCCCC(=O)Nc1cc2[nH]c(C3CCCCC3)nc2cc1N(CC)CC.CCCOC(=O)Nc1cc2[nH]c(C3CCCCC3)nc2cc1N(CC)CC.CCN(CC)c1cc2nc(C3CCCCC3)[nH]c2cc1NC(=O)C1CCCC1.CCN(CC)c1cc2nc(C3CCCCC3)[nH]c2cc1NC(=O)c1ccc(OC)cc1.CCN(CC)c1cc2nc(C3CCCCC3)[nH]c2cc1NC(=O)c1ccccc1
InChIInChI=1S/C25H32N4O2.C24H30N4O.C23H34N4O.C22H34N4O.C21H32N4O2.C21H32N4O/c1-4-29(5-2)23-16-21-20(26-24(27-21)17-9-7-6-8-10-17)15-22(23)28-25(30)18-11-13-19(31-3)14-12-18;1-3-28(4-2)22-16-20-19(25-23(26-20)17-11-7-5-8-12-17)15-21(22)27-24(29)18-13-9-6-10-14-18;1-3-27(4-2)21-15-19-18(24-22(25-19)16-10-6-5-7-11-16)14-20(21)26-23(28)17-12-8-9-13-17;1-4-7-13-21(27)23-19-14-17-18(15-20(19)26(5-2)6-3)25-22(24-17)16-11-9-8-10-12-16;1-4-12-27-21(26)24-18-13-16-17(14-19(18)25(5-2)6-3)23-20(22-16)15-10-8-7-9-11-15;1-4-10-20(26)22-18-13-16-17(14-19(18)25(5-2)6-3)24-21(23-16)15-11-8-7-9-12-15/h11-17H,4-10H2,1-3H3,(H,26,27)(H,28,30);6,9-10,13-17H,3-5,7-8,11-12H2,1-2H3,(H,25,26)(H,27,29);14-17H,3-13H2,1-2H3,(H,24,25)(H,26,28);14-16H,4-13H2,1-3H3,(H,23,27)(H,24,25);13-15H,4-12H2,1-3H3,(H,22,23)(H,24,26);13-15H,4-12H2,1-3H3,(H,22,26)(H,23,24)
InChIKeyMAPYZOSVNPTYLQ-UHFFFAOYSA-N
XLogP33.21
TPSA384.58 Ų
H-Bond Donors12
H-Bond Acceptors20
Rotatable Bonds41
Heavy Atoms168
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002293.21
LogP ≤ 533.21
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1020

Analyze N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]benzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]butanamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]cyclopentanecarboxamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]-4-methoxybenzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]pentanamide;propyl N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]-4-ethylbenzamide
CID 72793866
4-chloro-N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]benzamide
CID 25101001
N-[2-cyclohexyl-6-(dimethylamino)-3H-benzimidazol-5-yl]-2-(4-methoxyphenyl)acetamide
CID 72793662
N-[2-cyclohexyl-6-(dimethylamino)-3H-benzimidazol-5-yl]-4-propylbenzamide
CID 71738019
1-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]-3-propylurea
CID 72793846
N-[6-(diethylamino)-2-(2-methoxyphenyl)-3H-benzimidazol-5-yl]cyclopropanecarboxamide
CID 59530501
N-[6-(diethylamino)-2-(4-fluorophenyl)-3H-benzimidazol-5-yl]-4-methoxybenzamide
CID 59530569
N-[6-(diethylamino)-2-(4-fluorophenyl)-3H-benzimidazol-5-yl]cyclohexanecarboxamide
CID 59530587
4-chloro-N-[6-(diethylamino)-2-(4-methoxyphenyl)-3H-benzimidazol-5-yl]benzamide
CID 59530548
N-(2-cyclopentyl-3H-benzimidazol-5-yl)butanamide
CID 110779431
4-tert-butyl-N-[6-(diethylamino)-2-phenyl-3H-benzimidazol-5-yl]benzamide
CID 68511451
N-(2-cyclohexyl-3H-benzimidazol-5-yl)-3-methoxybenzamide;N-methylmethanamine
CID 118096520

Frequently Asked Questions

What is the IUPAC name of N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]benzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]butanamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]cyclopentanecarboxamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]-4-methoxybenzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]pentanamide;propyl N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]carbamate?
The IUPAC name of N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]benzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]butanamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]cyclopentanecarboxamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]-4-methoxybenzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]pentanamide;propyl N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]carbamate (CID 159511219) is N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]benzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]butanamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]cyclopentanecarboxamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]-4-methoxybenzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]pentanamide;propyl N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]carbamate.
What is the SMILES notation for N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]benzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]butanamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]cyclopentanecarboxamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]-4-methoxybenzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]pentanamide;propyl N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]carbamate?
The canonical SMILES for N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]benzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]butanamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]cyclopentanecarboxamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]-4-methoxybenzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]pentanamide;propyl N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]carbamate is CCCC(=O)Nc1cc2[nH]c(C3CCCCC3)nc2cc1N(CC)CC.CCCCC(=O)Nc1cc2[nH]c(C3CCCCC3)nc2cc1N(CC)CC.CCCOC(=O)Nc1cc2[nH]c(C3CCCCC3)nc2cc1N(CC)CC.CCN(CC)c1cc2nc(C3CCCCC3)[nH]c2cc1NC(=O)C1CCCC1.CCN(CC)c1cc2nc(C3CCCCC3)[nH]c2cc1NC(=O)c1ccc(OC)cc1.CCN(CC)c1cc2nc(C3CCCCC3)[nH]c2cc1NC(=O)c1ccccc1.
What is the InChIKey of N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]benzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]butanamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]cyclopentanecarboxamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]-4-methoxybenzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]pentanamide;propyl N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]carbamate?
The InChIKey is MAPYZOSVNPTYLQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H32N4O2.C24H30N4O.C23H34N4O.C22H34N4O.C21H32N4O2.C21H32N4O/c1-4-29(5-2)23-16-21-20(26-24(27-21)17-9-7-6-8-10-17)15-22(23)28-25(30)18-11-13-19(31-3)14-12-18;1-3-28(4-2)22-16-20-19(25-23(26-20)17-11-7-5-8-12-17)15-21(22)27-24(29)18-13-9-6-10-14-18;1-3-27(4-2)21-15-19-18(24-22(25-19)16-10-6-5-7-11-16)14-20(21)26-23(28)17-12-8-9-13-17;1-4-7-13-21(27)23-19-14-17-18(15-20(19)26(5-2)6-3)25-22(24-17)16-11-9-8-10-12-16;1-4-12-27-21(26)24-18-13-16-17(14-19(18)25(5-2)6-3)23-20(22-16)15-10-8-7-9-11-15;1-4-10-20(26)22-18-13-16-17(14-19(18)25(5-2)6-3)24-21(23-16)15-11-8-7-9-12-15/h11-17H,4-10H2,1-3H3,(H,26,27)(H,28,30);6,9-10,13-17H,3-5,7-8,11-12H2,1-2H3,(H,25,26)(H,27,29);14-17H,3-13H2,1-2H3,(H,24,25)(H,26,28);14-16H,4-13H2,1-3H3,(H,23,27)(H,24,25);13-15H,4-12H2,1-3H3,(H,22,23)(H,24,26);13-15H,4-12H2,1-3H3,(H,22,26)(H,23,24).
What are the key properties of N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]benzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]butanamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]cyclopentanecarboxamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]-4-methoxybenzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]pentanamide;propyl N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]carbamate?
N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]benzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]butanamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]cyclopentanecarboxamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]-4-methoxybenzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]pentanamide;propyl N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]carbamate has a molecular weight of 2293.21 g/mol, XLogP of 33.21, 41 rotatable bonds, 12 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]benzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]butanamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]cyclopentanecarboxamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]-4-methoxybenzamide;N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]pentanamide;propyl N-[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]carbamate is sourced from PubChem (CID 159511219), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).